{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:38:32Z","timestamp":1786365512970,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"W.H. Odell Professorship in Individualized Medicine"},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["K12 CA90628"],"award-info":[{"award-number":["K12 CA90628"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1245\/s10434-025-18027-9","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T12:15:01Z","timestamp":1755087301000},"page":"8129-8139","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Is the Clipped Node Enough? Successful Retrieval and False Negative Rate of the Clipped Node After Neoadjuvant Chemotherapy"],"prefix":"10.1245","volume":"32","author":[{"given":"Candice N.","family":"Santoro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya L.","family":"Hoskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie A.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy C.","family":"Boughey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary M.","family":"Mrdutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"issue":"12","key":"18027_CR1","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1158\/1078-0432.CCR-19-3492","volume":"26","author":"LM Spring","year":"2020","unstructured":"Spring LM, Fell G, Arfe A, et al. Pathologic complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: a comprehensive meta-analysis. Clin Cancer Res. 2020;26(12):2838\u201348. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-3492.","journal-title":"Clin Cancer Res"},{"issue":"14","key":"18027_CR2","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2013.278932","volume":"310","author":"JC Boughey","year":"2013","unstructured":"Boughey JC, Suman VJ, Mittendorf EA, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013;310(14):1455\u201361. https:\/\/doi.org\/10.1001\/jama.2013.278932.","journal-title":"JAMA"},{"issue":"7","key":"18027_CR3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","volume":"14","author":"T Kuehn","year":"2013","unstructured":"Kuehn T, Bauerfeind I, Fehm T, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013;14(7):609\u201318. https:\/\/doi.org\/10.1016\/S1470-2045(13)70166-9.","journal-title":"Lancet Oncol"},{"issue":"3","key":"18027_CR4","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","volume":"33","author":"JF Boileau","year":"2015","unstructured":"Boileau JF, Poirier B, Basik M, et al. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol. 2015;33(3):258\u201364. https:\/\/doi.org\/10.1200\/JCO.2014.55.7827.","journal-title":"J Clin Oncol"},{"issue":"2","key":"18027_CR5","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10549-018-5004-7","volume":"173","author":"JM Classe","year":"2019","unstructured":"Classe JM, Loaec C, Gimbergues P, et al. Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study. Breast Cancer Res Treat. 2019;173(2):343\u201352. https:\/\/doi.org\/10.1007\/s10549-018-5004-7.","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"18027_CR6","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1002\/bjs.7073","volume":"97","author":"ME Straver","year":"2010","unstructured":"Straver ME, Loo CE, Alderliesten T, Rutgers EJ, Vrancken Peeters MT. Marking the axilla with radioactive iodine seeds (MARI procedure) may reduce the need for axillary dissection after neoadjuvant chemotherapy for breast cancer. Br J Surg. 2010;97(8):1226\u201331. https:\/\/doi.org\/10.1002\/bjs.7073.","journal-title":"Br J Surg"},{"issue":"2","key":"18027_CR7","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/SLA.0000000000000558","volume":"261","author":"M Donker","year":"2015","unstructured":"Donker M, Straver ME, Wesseling J, et al. Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure. Ann Surg. 2015;261(2):378\u201382. https:\/\/doi.org\/10.1097\/SLA.0000000000000558.","journal-title":"Ann Surg"},{"key":"18027_CR8","doi-asserted-by":"publisher","first-page":"104411","DOI":"10.1016\/j.breast.2025.104411","volume":"80","author":"AKE van Hemert","year":"2025","unstructured":"van Hemert AKE, van Loevezijn AA, Baas MPD, et al. Omitting axillary lymph node dissection in breast cancer patients with extensive nodal disease and excellent response to primary systemic therapy using the MARI protocol. Breast. 2025;80:104411. https:\/\/doi.org\/10.1016\/j.breast.2025.104411.","journal-title":"Breast"},{"issue":"2","key":"18027_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1001\/jamasurg.2014.1086","volume":"150","author":"AS Caudle","year":"2015","unstructured":"Caudle AS, Yang WT, Mittendorf EA, et al. Selective surgical localization of axillary lymph nodes containing metastases in patients with breast cancer: a prospective feasibility trial. JAMA Surg. 2015;150(2):137\u201343. https:\/\/doi.org\/10.1001\/jamasurg.2014.1086.","journal-title":"JAMA Surg"},{"issue":"4","key":"18027_CR10","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1097\/SLA.0000000000001375","volume":"263","author":"JC Boughey","year":"2016","unstructured":"Boughey JC, Ballman KV, Le-Petross HT, et al. Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0\u2013T4, N1\u2013N2) who receive neoadjuvant chemotherapy: results from ACOSOG Z1071 (Alliance). Ann Surg. 2016;263(4):802\u20137. https:\/\/doi.org\/10.1097\/SLA.0000000000001375.","journal-title":"Ann Surg"},{"key":"18027_CR11","unstructured":"National Comprehensive Cancer Network. Breast cancer (version 4.2025). Available at: www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf. Accessed 22 Apr 2025."},{"issue":"12","key":"18027_CR12","doi-asserted-by":"publisher","first-page":"4795","DOI":"10.1245\/s10434-020-08900-0","volume":"27","author":"MA Piltin","year":"2020","unstructured":"Piltin MA, Hoskin TL, Day CN, Davis J Jr, Boughey JC. Oncologic outcomes of sentinel lymph node surgery after neoadjuvant chemotherapy for node-positive breast cancer. Ann Surg Oncol. 2020;27(12):4795\u2013801. https:\/\/doi.org\/10.1245\/s10434-020-08900-0.","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"18027_CR13","doi-asserted-by":"publisher","first-page":"6401","DOI":"10.1245\/s10434-023-13759-y","volume":"30","author":"JC Boughey","year":"2023","unstructured":"Boughey JC, Yu H, Dugan CL, et al. Changes in surgical management of the axilla over 11 years\u2013report on more than 1500 breast cancer patients treated with neoadjuvant chemotherapy on the prospective I-SPY2 trial. Ann Surg Oncol. 2023;30(11):6401\u201310. https:\/\/doi.org\/10.1245\/s10434-023-13759-y.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"18027_CR14","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3322\/caac.21393","volume":"67","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Connolly JL, Edge SB, et al. Breast cancer-major changes in the American joint committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(4):290\u2013303. https:\/\/doi.org\/10.3322\/caac.21393.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"18027_CR15","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1245\/s10434-024-16625-7","volume":"32","author":"A Laws","year":"2025","unstructured":"Laws A, Leonard S, Vincuilla J, et al. Risk of surgical overtreatment in cN1 breast cancer patients who become ypN0 after neoadjuvant chemotherapy: SLNB versus TAD. Ann Surg Oncol. 2025;32(3):2023\u20138. https:\/\/doi.org\/10.1245\/s10434-024-16625-7.","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"18027_CR16","doi-asserted-by":"publisher","first-page":"7249","DOI":"10.1245\/s10434-024-15792-x","volume":"31","author":"KM Switalla","year":"2024","unstructured":"Switalla KM, Boughey JC, Dimitroff K, et al. Clipping the positive lymph node in patients with clinically node positive breast cancer treated with neoadjuvant chemotherapy: impact on axillary surgery in the ISPY-2 clinical trial. Ann Surg Oncol. 2024;31(11):7249\u201359. https:\/\/doi.org\/10.1245\/s10434-024-15792-x.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"18027_CR17","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","volume":"34","author":"AS Caudle","year":"2016","unstructured":"Caudle AS, Yang WT, Krishnamurthy S, et al. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection. J Clin Oncol. 2016;34(10):1072\u20138. https:\/\/doi.org\/10.1200\/JCO.2015.64.0094.","journal-title":"J Clin Oncol"},{"issue":"11","key":"18027_CR18","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1245\/s10434-007-9494-5","volume":"14","author":"SD Nathanson","year":"2007","unstructured":"Nathanson SD, Burke M, Slater R, Kapke A. Preoperative identification of the sentinel lymph node in breast cancer. Ann Surg Oncol. 2007;14(11):3102\u201310. https:\/\/doi.org\/10.1245\/s10434-007-9494-5.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"18027_CR19","doi-asserted-by":"publisher","first-page":"6133","DOI":"10.1245\/s10434-022-12240-6","volume":"29","author":"G Montagna","year":"2022","unstructured":"Montagna G, Lee MK, Sevilimedu V, Barrio AV, Morrow M. Is nodal clipping beneficial for node-positive breast cancer patients receiving neoadjuvant chemotherapy? Ann Surg Oncol. 2022;29(10):6133\u20139. https:\/\/doi.org\/10.1245\/s10434-022-12240-6.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"18027_CR20","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1001\/jamaoncol.2021.4394","volume":"7","author":"AV Barrio","year":"2021","unstructured":"Barrio AV, Montagna G, Mamtani A, et al. Nodal recurrence in patients with node-positive breast cancer treated with sentinel node biopsy alone after neoadjuvant chemotherapy-a rare event. JAMA Oncol. 2021;7(12):1851\u20135. https:\/\/doi.org\/10.1001\/jamaoncol.2021.4394.","journal-title":"JAMA Oncol"},{"issue":"5","key":"18027_CR21","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1245\/s10434-025-16973-y","volume":"32","author":"JC Boughey","year":"2025","unstructured":"Boughey JC, Yu H, Switalla K, et al. Oncologic outcomes with de-escalation of axillary surgery after neoadjuvant chemotherapy for breast cancer: results from > 1500 patients on the I-SPY2 clinical trial. Ann Surg Oncol. 2025;32(5):3278\u201391. https:\/\/doi.org\/10.1245\/s10434-025-16973-y.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"18027_CR22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1001\/jamasurg.2024.5913","volume":"160","author":"N Cabioglu","year":"2025","unstructured":"Cabioglu N, Kocer HB, Karanlik H, et al. De-escalation of nodal surgery in clinically node-positive breast cancer. JAMA Surg. 2025;160(3):257\u201366. https:\/\/doi.org\/10.1001\/jamasurg.2024.5913.","journal-title":"JAMA Surg"},{"issue":"7","key":"18027_CR23","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1097\/JS9.0000000000000331","volume":"109","author":"SY Wu","year":"2023","unstructured":"Wu SY, Li JW, Wang YJ, et al. Clinical feasibility and oncological safety of non-radioactive targeted axillary dissection after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: a prospective diagnostic and prognostic study. Int J Surg. 2023;109(7):1863\u201370. https:\/\/doi.org\/10.1097\/JS9.0000000000000331.","journal-title":"Int J Surg"},{"issue":"6","key":"18027_CR24","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1001\/jamaoncol.2024.0578","volume":"10","author":"G Montagna","year":"2024","unstructured":"Montagna G, Mrdutt MM, Sun SX, et al. Omission of axillary dissection following nodal downstaging with neoadjuvant chemotherapy. JAMA Oncol. 2024;10(6):793\u20138. https:\/\/doi.org\/10.1001\/jamaoncol.2024.0578.","journal-title":"JAMA Oncol"},{"issue":"12","key":"18027_CR25","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1245\/s10434-010-1155-4","volume":"17","author":"JI Goldberg","year":"2010","unstructured":"Goldberg JI, Wiechmann LI, Riedel ER, Morrow M, Van Zee KJ. Morbidity of sentinel node biopsy in breast cancer: the relationship between the number of excised lymph nodes and lymphedema. Ann Surg Oncol. 2010;17(12):3278\u201386. https:\/\/doi.org\/10.1245\/s10434-010-1155-4.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"18027_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4048\/jbc.2021.24.e9","volume":"24","author":"HK Kim","year":"2021","unstructured":"Kim HK, Ju YW, Lee JW, et al. Association between number of retrieved sentinel lymph nodes and breast cancer-related lymphedema. J Breast Cancer. 2021;24(1):63\u201374. https:\/\/doi.org\/10.4048\/jbc.2021.24.e9.","journal-title":"J Breast Cancer"},{"issue":"10","key":"18027_CR27","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1245\/s10434-011-1688-1","volume":"18","author":"JI Goldberg","year":"2011","unstructured":"Goldberg JI, Riedel ER, Morrow M, Van Zee KJ. Morbidity of sentinel node biopsy: relationship between number of excised lymph nodes and patient perceptions of lymphedema. Ann Surg Oncol. 2011;18(10):2866\u201372. https:\/\/doi.org\/10.1245\/s10434-011-1688-1.","journal-title":"Ann Surg Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18027-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18027-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18027-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T16:06:37Z","timestamp":1759507597000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18027-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["18027"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18027-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"assertion":[{"value":"25 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Judy C. Boughey receives research funding, paid to her institution, from Eli Lilly, SimBioSys and Quantum Lep Healthcare, and is on the Data Safety Monitoring Board for Cairns Surgical. Candice N. Santoro, Tanya L. Hoskin, Carrie A. Olson, and Mary M. Mrdutt have no conflicts of interest to declare that may be relevant to the contents of this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}